VBIO Stock Price, News & Analysis

VBIO OTC

Company Description

VBIO (OTC: VBIO) is a publicly traded medicinal and botanical manufacturing company in the Manufacturing sector.

This page provides a comprehensive overview of VBIO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

50.8M

Shares outstanding

Latest News

View All

September 3, 2021

—

Vitality Biopharma Announces Effective S-1 Registration Statement and DTC Eligibility

August 20, 2021

—

Vitality Biopharma Enters Into $5 Million Equity Line Financing Relationship With Institutional Investor

August 10, 2021

—

FDA Grants Vitality Biopharma Orphan Drug Designation for VBX-100 Prodrug

clinical trial fda approval

VBIO has 3 recent news articles. Key topics include clinical trial, fda approval. View all VBIO news →

SEC Filings

View All

No SEC filings available for VBIO.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

VBIO Company Profile & Sector Positioning

VBIO (VBIO) operates in the Medicinal and Botanical Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.